For decades, taking a daily low-dose aspirin was a widely accepted practice for preventing heart attacks and strokes. But a series of clinical trials have led to a major shift in medical guidance — ...
Low-dose aspirin significantly reduced risk for colorectal cancer recurrence among patients with mutations in the PI3K ...
Hosted on MSN4d
Practice-Changing Win for Aspirin in Colorectal CancerIn an era dominated by pricey, high-tech drugs, the humble aspirin had a practice-changing impact on colorectal cancer (CRC) ...
Three-year results from the ALASCCA trial (NCT02647099), presented at the 2025 ASCO Gastrointestinal Cancer Symposium, showed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback